BioCentury | May 4, 2016
Financial News

MVM closes fourth fund at $233M

...healthcare IT plays. It has invested in pain company Cara Therapeutics Inc. (NASDAQ:CARA), osteoporosis company Tarsa Therapeutics Inc....
BioCentury | Nov 9, 2015
Clinical News

Oral salmon calcitonin regulatory update

...see BioCentury, Oct. 26, 2009 & May 27, 2013). Enteris BioPharma Inc. , Boonton, N.J. Tarsa Therapeutics Inc....
BioCentury | Sep 1, 2014
Financial News

Tarsa Therapeutics financial update

Tarsa Therapeutics Inc. , Philadelphia, Pa. Business: Musculoskeletal Date announced: 2014-08-13 Note: Tarsa secured a $10 million senior credit facility from Oxford Finance and Square 1 Bank. WIR Staff Musculoskeletal...
BioCentury | Jan 7, 2013
Finance

Buyside View XXI: Sunny side up

Stephen Hansen Senior Writer A strong crop of early PDUFA dates and a sense that FDA is more navigable have given money managers in the U.S. and Europe a positive outlook for 2013, which they...
BioCentury | Oct 22, 2012
Clinical News

Oral salmon calcitonin: Phase II data

...provide additional guidance on an MAA submission for Ostora pending the results of the appeal. Tarsa Therapeutics Inc....
BioCentury | Aug 20, 2012
Company News

Unigene musculoskeletal news

...see BioCentury, June 11 & Aug. 13). Unigene's Ostora oral recombinant salmon calcitonin, to which Tarsa Therapeutics Inc....
BioCentury | Apr 30, 2012
Finance

Foreseeing liquidity

...few years," he said. Investments include Intarcia Therapeutics Inc. ; Puma Biotechnology Inc . (OTCBB:PBYI); Tarsa Therapeutics Inc....
BioCentury | Mar 19, 2012
Company News

Tarsa Therapeutics board of directors update

Tarsa Therapeutics Inc. , Philadelphia, Pa. Business: Musculoskeletal Appointed: James Tananbaum, CEO of Foresite Capital WIR Staff Musculoskeletal...
BioCentury | Mar 19, 2012
Financial News

Tarsa Therapeutics completes venture financing

Tarsa Therapeutics Inc. , Philadelphia, Pa. Business: Musculoskeletal Date completed: 3/16/12 Type: Venture financing Raised: $28 million Investors: Foresite Capital; Novo A/S; MVM Life Science Partners; Quaker Partners WIR Staff Musculoskeletal...
BioCentury | Mar 16, 2012
Financial News

Tarsa adds $28 million in series B

Tarsa Therapeutics Inc. (Philadelphia, Pa.) raised $28 million in a series B round led by new investor Foresite Capital. Existing investors Novo A/S; MVM Life Science Partners; and Quaker Partners participated. Tarsa plans to submit...
Items per page:
1 - 10 of 33
BioCentury | May 4, 2016
Financial News

MVM closes fourth fund at $233M

...healthcare IT plays. It has invested in pain company Cara Therapeutics Inc. (NASDAQ:CARA), osteoporosis company Tarsa Therapeutics Inc....
BioCentury | Nov 9, 2015
Clinical News

Oral salmon calcitonin regulatory update

...see BioCentury, Oct. 26, 2009 & May 27, 2013). Enteris BioPharma Inc. , Boonton, N.J. Tarsa Therapeutics Inc....
BioCentury | Sep 1, 2014
Financial News

Tarsa Therapeutics financial update

Tarsa Therapeutics Inc. , Philadelphia, Pa. Business: Musculoskeletal Date announced: 2014-08-13 Note: Tarsa secured a $10 million senior credit facility from Oxford Finance and Square 1 Bank. WIR Staff Musculoskeletal...
BioCentury | Jan 7, 2013
Finance

Buyside View XXI: Sunny side up

Stephen Hansen Senior Writer A strong crop of early PDUFA dates and a sense that FDA is more navigable have given money managers in the U.S. and Europe a positive outlook for 2013, which they...
BioCentury | Oct 22, 2012
Clinical News

Oral salmon calcitonin: Phase II data

...provide additional guidance on an MAA submission for Ostora pending the results of the appeal. Tarsa Therapeutics Inc....
BioCentury | Aug 20, 2012
Company News

Unigene musculoskeletal news

...see BioCentury, June 11 & Aug. 13). Unigene's Ostora oral recombinant salmon calcitonin, to which Tarsa Therapeutics Inc....
BioCentury | Apr 30, 2012
Finance

Foreseeing liquidity

...few years," he said. Investments include Intarcia Therapeutics Inc. ; Puma Biotechnology Inc . (OTCBB:PBYI); Tarsa Therapeutics Inc....
BioCentury | Mar 19, 2012
Company News

Tarsa Therapeutics board of directors update

Tarsa Therapeutics Inc. , Philadelphia, Pa. Business: Musculoskeletal Appointed: James Tananbaum, CEO of Foresite Capital WIR Staff Musculoskeletal...
BioCentury | Mar 19, 2012
Financial News

Tarsa Therapeutics completes venture financing

Tarsa Therapeutics Inc. , Philadelphia, Pa. Business: Musculoskeletal Date completed: 3/16/12 Type: Venture financing Raised: $28 million Investors: Foresite Capital; Novo A/S; MVM Life Science Partners; Quaker Partners WIR Staff Musculoskeletal...
BioCentury | Mar 16, 2012
Financial News

Tarsa adds $28 million in series B

Tarsa Therapeutics Inc. (Philadelphia, Pa.) raised $28 million in a series B round led by new investor Foresite Capital. Existing investors Novo A/S; MVM Life Science Partners; and Quaker Partners participated. Tarsa plans to submit...
Items per page:
1 - 10 of 33